Optimization of the influenza neuraminidase inhibitor therapy by use of secondary bacterial infections
Identification and characterization of novel leads for neuraminidase (NA) inhibitors for the treatment of influenza that act on independently NAH resistances and, in addition, inhibit the NA of pneumonia inducing bacteria.
Novel approaches to predict the therapeutical outcome of NAH.
(2014) Within-host influenza dynamics: a small-scale mathematical modeling approach. Biosystems 118, 51-59.
Start of PhD
February 9, 2012
December 18, 2015